CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,303,568 | +20.7% | 341,478 | -1.4% | 0.08% | +10.4% |
| Q2 2023 | $7,708,980 | +2.0% | 346,471 | -0.7% | 0.08% | +11.6% |
| Q1 2023 | $7,555,225 | +1.1% | 348,810 | -5.2% | 0.07% | -83.9% |
| Q4 2022 | $7,471,379 | -22.7% | 367,867 | -2.4% | 0.43% | +102.8% |
| Q3 2022 | $9,663,000 | +5.8% | 376,855 | -1.9% | 0.21% | +16.6% |
| Q2 2022 | $9,137,000 | +4.0% | 384,231 | -1.5% | 0.18% | +25.7% |
| Q1 2022 | $8,783,000 | – | 389,999 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,188,417 | $85,349,000 | 7.80% |
| TANAKA CAPITAL MANAGEMENT INC | 144,602 | $2,379,000 | 5.69% |
| INGALLS & SNYDER LLC | 6,817,540 | $112,149,000 | 5.47% |
| NEXTHERA CAPITAL LP | 1,045,196 | $17,193,000 | 2.83% |
| Timpani Capital Management LLC | 245,279 | $4,035,000 | 1.41% |
| S&T BANK/PA | 426,257 | $7,012,000 | 1.25% |
| SHAKER INVESTMENTS LLC/OH | 107,670 | $1,771,000 | 1.10% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 434,624 | $7,150,000 | 0.94% |
| AMI ASSET MANAGEMENT CORP | 709,300 | $11,668,000 | 0.83% |
| Birchview Capital, LP | 75,500 | $1,242,000 | 0.82% |